Authors
Latest:
Personalized Solutions Boost Medication AdherenceFor the past 20 to 25 years, data has shown that half of patients prescribed long-term medications do not take them as prescribed.
Latest:
Frontline Forum Part 5: A Discussion of the Current Treatment Landscape for Atopic DermatitisIn part 5 of this Frontline Forum, Raj Chovatiya, MD, PhD; Neal D. Bhatia, MD; Alexandra K. Golant, MD; and Brett King, MD, PhD, discuss the rapidly changing use for JAK inhibitors and other agents for atopic dermatitis.
Latest:
Psoriasis Case ImpressionsMark G. Lebwohl, MD, and Joseph F. Merola, MD, MMSc, provide impressions to the case and take-home messages for dermatologists and rheumatologists treating psoriasis.
Latest:
Malignancy Risk Low in Secukinumab TreatmentA study finds low risk of malignancy from secukinumab treatment for psoriasis, psoriatic arthritis and ankylosing spondylitis patients, despite limited data.
Latest:
Continuing Medical Education: Three Things to Know About Pustular PsoriasisPustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.
Latest:
Amy Paller, MD, Discusses Long-Term Safety and Efficacy of Ixekizumab in KidsPaller discusses the findings of the clinical trial examining the long-term effects of ixekizumab for treating psoriasis in children.
Latest:
The Dx and Rx of Congenital Malalignment Syndrome in ChildrenCongenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Latest:
Real-World Study Shows Dupixent Improves AD Symptoms in Children Under 12 YearsA real-world study of children with moderate-to-severe atopic dermatitis (AD) in China found Dupixent can reduce symptoms and improve pruritus. Traditional therapies had little effect, according to the researchers.
Latest:
Pulsed Dye Lasers for Cosmetic ProceduresPulsed dye lasers are now being used for several different dermatologic conditions.
Latest:
New Tech for SkinThere are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Latest:
Treatment of Plaque Psoriasis in ChildrenA variety of topicals and biologics are now available to treat children affected by this challenging condition.
Latest:
Clinical Considerations for Monkeypox in PregnancyWhat we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Latest:
FDA approves topical for actinic keratosisTirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
Latest:
5 steps to make telehealth work for physicians and patientsThere are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.
Latest:
Psoriasis Associated with Increased Risk for Retinal DiseasesMore research is needed to understand the pathogenesis underlying this association.
Latest:
Dermatologic differences in a diverse populationUnderstanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.
Latest:
A Health Care Price Transparency Revolution is at HandPayers must make public the individual amounts their health plans pay providers across all types of services and locations, including hospitals, doctors’ offices, imaging centers, outpatient surgery centers and urgent care clinics.
Latest:
Opioid Use in Psoriatic Arthritis Is Associated With Higher Health Care Costs, UtilizationNew pathways of care are needed to improve health care spending.
Latest:
Will Kirby, DO, FAOCD, Talks With Dustin Portela, DO, FAADWill Kirby, DO, FAOCD, talks with Dustin Portela, DO, FAAD, about TikTok, what being a KOL really means, and the biggest aesthetic myth in the industry right now.
Latest:
Skin of Color Society Summit: An OverviewHiring investigators of color, educating and building trust with potential participants, and addressing funding can make clinical trials more diverse.
Latest:
Omicron COVID-19 variant: What we know and what we don’tThe Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.
Latest:
Optimizing Patient Outcomes with JAK InhibitorsBrett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Latest:
Non-Invasive Test That May Help Predict Eczema in BabiesResults from the test reveal that high levels of the immune biomarker Thymus and Activation-Regulated Chemokine (TARC) in babies increases their chances of developing atopic dermatitis.
Latest:
Can Supplements Effectively Manage Hair Loss?Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Latest:
What You Need to Know About Mentoring DoctorsDefining the goals of the mentoring relationship can be useful to clarify expectations.
Latest:
Clascoterone cream 1% targets androgen receptorsThe topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.
